NewPublishedDataConfirmsNemluvio(Nemolizumab)CanRapidlyRelieveItchandImproveSleepinasEarlyasTwoDaysinBothAtopicDermatitisandPrurigoNodularis
===2025/12/17 17:06:43===
ailableonline
Kwatra SG. Breaking the itch–scratch cycle in prurigo nodularis.N Engl J Med. 2020;382(8):757-758. doi:10.1056/NEJMe1916733
Contacts
For further information:
Christian Marcoux, M.Sc.
Chief Communications Officer
christian.marcoux@galderma.com
+41 76 315 26 50
Richard Harbinson
Corporate Communications Director
richard.harbinson@galderma.com
+41 76 210 60 62
Céline Buguet
Franchises and R&D Communications Director
celine.buguet@galderma.com
+41 76 249 90 87
Emil Ivanov
Head of Strategy, Investor Relations, and ESG
emil.ivanov@galderma.com
+41 21 642 78 12
Jessica Cohen
Investor Relations and Strategy Director
jessica.cohen@galderma.com
+41 21 642 76 43
=*=*=*=*=*=
当前为第16/16页
上一页-
=*=*=*=*=*=
返回新闻列表
返回网站首页